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Relationship between Diabetes Mellitus and Thyroid 
Dysfunction
Thyroid dysfunction and diabetes mellitus (DM) are the two most common endocrine disorders.
Approximately 4 million people in the United States are hypothyroid and receive thyroxine
replacement therapy. By contrast, hyperthyroidism is much less common, with a female-to-
male ratio of 9:1
The total prevalence of DM is increasing and is projected to rise to 366 million worldwide in
2030, affecting 4·4% of all age groups. Today, an increase in prevalence is confirmed among
individuals >65 years of age .
The frequency of thyroid dysfunction in diabetic patients is higher than that of the general
population: according to the American Diabetes Assocation’s 2016 Standards of Medical Care
in Diabetes, autoimmune thyroid disease occurs in 17 to 30 percent of people with type 1.
The pathophysiological basis of this association rests on a complex interaction of common
signalling pathways and, in the case of type 1 diabetes and autoimmune thyroid disease, on a
linked genetic susceptibility.
Leonidas H. Duntas; Jacques Orgiazzi; Georg Brabant Clin Endocrinol. 2011;75(1):1-9.
http://www.medscape.com/viewarticle/745282_2
http://journal.diabetes.org/clinicaldiabetes/v18n12000/pg38.htm
Objective of the studies
Establishment of the relationship between diabetes mellitus and thyroid dysfunction
(hypothyroidism and hyperthyroidism)
Comparison of the blood glucose and HbA1c levels, creatinine and BP levels in
diabetics with and diabetics without thyroid problems.
To evaluate association of complications of diabetes mellitus and thyroid dysfunctions.
Methodology
• Retrospective study included 196 patients diagnosed with diabetes mellitus, treated in 13 Kharkiv 
city hospital, with or  without thyroid disorders (hypothyroidism, hyperthyroidism).
• Diagnoses of Diabetes Mellitus, Hypo-, Hyper- and Euthyroidism were maiden and confirmed by 
13 Kharkiv city hospital endocrinologist
• These parameters were analysed: duration of diabetes mellitus, levels of fasting blood sugar, 
HbA1c, creatinine, blood pressure, incidence of diabetes complications in all groups
•Data was analysed with Microsoft Office Excel and Statistica 7
• Study limitations: small groups of patients with thyroid disorders in combination with DM
Descriptive characteristics of  patients included in study
Data has been presented as absolute count (percentage); Age, systolic and diastolic pressures and duration of DM are represented as mean ± standard error of mean;
DM – diabetes mellitus, BP – blood preasure
Demographic Variables DM + Hypothyroidism
(1) (36 patients)
DM  + 
Hyperthyroidism
(2)  (6 patients)
DM + Euthyroidism
(51 patients)
(3)
DM
(106 patients)
(4)
P-value
Sex
Male 15 (42%) 1 (17%) 13 (25%) 36 (34%)
0.348
Female 21 (58%) 5 (83%) 38 (75%) 70 (66%)
Age 62 ± 2 71 ± 3 62 ± 2 63 ± 1 0.336
DM  types
Type 1 2 (6%) 0 (0.0) 3 (6%) 9 (9%)
0.796
Type 2                     34 (94%) 6 (100%) 48 (94%) 97 (91%)
Systolic pressure 161 ± 6 148 ± 2 142 ± 2 146 ± 2 < 0.05
Diastolic pressure 97 ± 4 83 ± 5 80 ± 1 86 ± 1 <0.0001
Duration of DM (years) 7 ± 1 7 ± 3 8 ± 1 7 ± 1 0.836
Hypertension groups
Normal BP 0 (0.0) 0 (0.0) 1 (2%) 6 (6%)
2- 1,3,4 -< 0.05
1-4– 0.02
1-3 – 0.001
Pre-hypertension 10 (27%) 0 (0.0) 18 (35%) 22 (20%)
Stage 1 14 (39%) 1 (17%) 27 (53%) 57 (54%)
Stage 2 2 (5%) 0 (0.0) 3 (6%) 6 (6%)
Stage 3 10 (29%) 6 (83%) 2 (4%) 15 (14%)
DM hyperglycemia control among study subjects
Data has been presented as mean ± standard error of mean
Groups HBA1C (%) Fasting Glucose (mmol/L) Creatinine (mg/dL)
DM + Hypothyroidism 7.73 ± 0.29 10.18 ± 0.72 0.19 ± 0.04
DM + Hyperthyroidism 7.48 ± 0.81 16.25 ± 3.07 0.18 ± 0.01
DM + Euthyroidism 6.89 ± 0.17 9.07 ± 0.35 0.17 ± 0.04
DM 6.95 ± 0.11 9.21 ± 0.39 0.15 ± 0.02
P-value 0.01 <0.05 > 0.05
p
-
0
.0
2
p
-
0
.0
2
Complications
1group DM + 
Hypothyroidism
(patients, %)
2 group DM + 
Hyperthyroidism
(patients, %)
3 group DM + 
Euthyroidism
(patients, %)
4 group DM
(patients, %)
p
Stroke 2 (5%) 5 (83%) 1 (2%) 3 (3%) 1-2 groups – 0,0001
MI 2 (5%) 0 (0.0) 2 (4%) 2 (1.8%)
> 0.05
Diabetic nephropathy 21 (58%) 6 (100%) 20 (39%) 60 (57%)
1-2 groups – 0,03
2-4 groups – 0,02
CHF 29 (80%) 6 (100%) 36 (70%) 66 (62%)
1-4 groups – 0,04
1-2 groups – 0,001
2-4 groups – 0,01
2-3 groups – 0,005
Rate of DM complications among study subjects
Correlations of HbA1c level in study groups, p < 0.05
creatinine levels SAP  level DAP  level leucocytes in CBC
DM + Hypothyroidism 0,27 - 0,16 - 0,17 0,12
DM + Hyperthyroidism 0,5 0,30 0,41 - 0,12
DM + Euthyroidism - 0,19 0,21 0,28 0,09
DM - 0,10 0,06 - 0,01 - 0,02
DM – diabetes mellitus, MI- myocardial infarction, CHF – chronic heart failure
Discussion
There was relationship between diabetes mellitus and thyroid dysfunction.
Both fasting blood glucose and HbA1c level were markedly raised in both thyroid disorders (hypo- and hyper-),
but level of HbA1c was higher in DM + Hypothyroidism group. That proves non-optimal hyperglycemia control
in this patient’s group and could be explained by increased insulin resistance, due to reduced rate of insulin
degradation in hypothyroidism which may lower the exogenous insulin requirement. Otherwise, uncontrolled
hyperglycemia may lead to an impairment in peripheral conversion of T4 to T3, reducing of T3 levels and
worsening of hypothyroidism outcome with enlarged dosages of replacement therapy needed. Studies done in
hypothyroid patients showed elevated HbA1c not only in the presence of diabetes but also in non-diabetic
subjects (Diabetes Care. 2010 Dec;33(12):2546-8)
Diabetes with hypothyroidism patients had a significantly higher levels of blood pressure as in other groups.
This possibly can be explained by association of Hypothyroidism and T3 deficiency with peripheral
vasoconstriction and increased arterial stiffness which may occur before or during the early stages of
atherosclerosis and appearance of micro and macrovascular DM complications. Early systolic arrival of the
reflected waves – from the peripheral arteries to the heart – increases central aortic BP and augments systolic
BP. the other hand, the increased systolic and diastolic BP could induce changes in the arterial wall, reducing
elasticity and increasing stiffness (https://www.hindawi.com/journals/jtr/2011/439463/).
Discussion
Diabetics with hyperthyroidism patients had a significantly higher levels of 3 stage arterial hypertension and
incidence of chronic heart failure as in other groups despite prescribed antyhypertensive treatment. This possibly
can be explained by in thyroid hormones effects as increasing of the heart rate, cardiac contractility, systolic and
mean pulmonary artery pressure, cardiac output, diastolic relaxation, atrial arrhythmias and myocardial oxygen
consumption, the depression of myocardial contractility, increased β-adrenergic activity, accompanied by increased
density of β-adrenergic receptors in the renal cortex, resulting in increased plasma renin, angiotensin II, and serum
angiotensin converting enzyme levels especially in elderly patients (www.eje-online.org/content/167/5/609.full).
Also in DM + hyperthyroidism group level of Diabetic nephropathy incidence was significantly higher than in
other groups, exist positive correlation between HbA1c and creatinine levels (higher level of HbA1c is– higher
level of creatinine will be). Well known that hyperthyroidism results in intra-glomerular hypertension (increased
filtration pressure) and consequent hyperfiltration. Also it predisposes to proteinuria, which is known to cause direct
renal injury and hyperthyroidism-induced increased mitochondrial energy metabolism along with down-regulation
of superoxide dismutase contributes to the increased free radical generation and consequent renal injury (Eur J
Endocrinol. 2006 Feb; 154(2):197-212). Because the kidneys play a role in glucose homeostasis, in patients with DM
decreased renal gluconeogenesis, microvascular changes, decreased insulin clearance, and inflammation-induce
insulin resistance is a base of renal injury in patients with DM (Diabetology & Metabolic Syndrome, 2016 May, 8:50).
Conclusion
• Diabetes and thyroid disorders have been shown to mutually influence each other and
associations between both conditions have long been reported. Compensation of thyroid
function due to adequate therapy leads to controlled hyperglycemia, less frequency of
DM and better DM outcome
• Hyperthyroidism as hypothyroidism impairs glycemic control in diabetic subjects, but
hypothyroidism patients alter carbohydrate metabolism with inability to gain stable
compensation of DM compering with euthyroidism and DM without thyroid
dysfunction
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